Composite Microspheres of Rosin Gum and Ethyl cellulose for Controlled Release of an Anti-diabetic Drug: in-vitro and in-vivo Assessment

2014 ◽  
Vol 4 (3) ◽  
pp. 227-235 ◽  
Author(s):  
K. Niharika ◽  
H.M. Nanjappaiah ◽  
Akram A. Naikawadi ◽  
Raghavendra V. Kulkarni
Keyword(s):  
Controlled Release ◽  
Ethyl Cellulose ◽  
Composite Microspheres ◽  
Rosin Gum ◽  
In Vivo Assessment

scholarly journals In vitro and in vivo assessment of controlled release and degradation of acoustically responsive scaffolds

2016 ◽  
Vol 46 ◽  
pp. 221-233 ◽  
Author(s):  
Alexander Moncion ◽  
Keith J. Arlotta ◽  
Eric G. O’Neill ◽  
Melissa Lin ◽  
Lily A. Mohr ◽  
...  
Keyword(s):  
Controlled Release ◽  
In Vivo Assessment

Tranexamic acid loaded gellan gum-based polymeric microbeads for controlled release: In vitro and in vivo assessment

2013 ◽  
Vol 112 ◽  
pp. 483-491 ◽  
Author(s):  
Shiv Sankar Bhattacharya ◽  
Subham Banerjee ◽  
Purojit Chowdhury ◽  
Amitava Ghosh ◽  
Rahul Rama Hegde ◽  
...  
Keyword(s):  
Controlled Release ◽  
Tranexamic Acid ◽  
Gellan Gum ◽  
Release In Vitro ◽  
In Vivo Assessment

scholarly journals In vivo assessment of a single adenine mutation in 5′UTR of Endothelin-1 gene in paediatric cases with severe pulmonary hypertension: an observational study

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Abhishek Kumar ◽  
Minati Choudhury ◽  
Sakshi Dhingra Batra ◽  
Kriti Sikri ◽  
Anushree Gupta
Keyword(s):  
Pulmonary Hypertension ◽  
Congenital Heart ◽  
Small Sample Size ◽  
Small Sample ◽  
Severe Pulmonary Hypertension ◽  
Endothelin 1 ◽  
Circulating Levels ◽  
In Vivo Assessment

Abstract Objective Endothelin-1 plays an important role in the pathogenesis of severe pulmonary hypertension. The + 139 ‘A’, adenine insertion variant in 5′UTR of edn1 gene has been reported to be associated with increased expression of Endothelin-1 in vitro. The aim of present study was to explore the association of this variant with the circulating levels of Endothelin-1 in vivo using archived DNA and plasma samples from 38 paediatric congenital heart disease (cyanotic and acyanotic) patients with severe pulmonary hypertension. Results The plasma Endothelin-1 levels were highly varied ranging from 1.63 to75.16 pg/ml. The + 139 ‘A’ insertion variant in 5′UTR of edn1 was seen in 8 out of 38 cases with only one acyanotic sample demonstrating homozygosity of inserted ‘A’ allele at + 139 site (4A/4A genotype). The plasma Endothelin-1 levels in children with homozygous variant 3A/3A genotype were comparable in cyanotic and acyanotic groups. Lone 4A/4A acyanotic sample had ET-1 levels similar to the median value of ET-1 associated with 3A/3A genotype and was absent in cyanotic group presumably due to deleterious higher ET-1 levels. The discussed observations, limited by the small sample size, are suggestive of homozygous adenine insertion variant posing a risk in cyanotic babies with Severe Pulmonary Hypertension.

scholarly journals Berberine-Coated Biomimetic Composite Microspheres for Simultaneously Hemostatic and Antibacterial Performance

Polymers ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 360
Author(s):  
Xiaojian Zhang ◽  
Kaili Dai ◽  
Chenyu Liu ◽  
Haofeng Hu ◽  
Fulin Luo ◽  
...  
Keyword(s):  
In Vitro Test ◽  
Water Emulsion ◽  
Biomedical Material ◽  
Composite Microspheres ◽  
Antibacterial Performance ◽  
New Strategy ◽  
Oil In Water Emulsion ◽  
Hemostatic Powder

Biomimetic microspheres containing alginate/carboxymethylcellulose/gelatin and coated with 0%, 1%, 3%, and 6% berberine (BACG, BACG-1B, BACG-3B, BACG-6B) were prepared by the oil-in-water emulsion method combined with spray drying. Through a series of physicochemical parameters and determination of hemostatic properties in vitro and in vivo, the results indicated that BACG and BACG-Bs were effective in inducing platelet adhesion/aggregation and promoting the hemostatic potential due to their biomimetic structure and rough surface. In addition, BACG-6B with high berberine proportion presented better hemostatic performance compared with the commercial hemostatic agent compound microporous polysaccharide hemostatic powder (CMPHP). BACG-6B also showed strong antibacterial activity in the in vitro test. The hemolysis test and cytotoxicity evaluation further revealed that the novel composite biomaterials have good hemocompatibility and biocompatibility. Thus, BACG-6B provides a new strategy for developing a due-functional (hemostat/antibacterial) biomedical material, which may have broad and promising applications in the future.

scholarly journals In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa

1985 ◽  
Vol 15 (suppl A) ◽  
pp. 201-206 ◽  
Author(s):  
A. U. Gerber ◽  
C. Feller-Segessenmann
Keyword(s):  
Pseudomonas Aeruginosa ◽  
In Vivo Assessment
Sign in / Sign up

Export Citation Format

Share Document